NCT06919692
Maternal Left Lateral Position in Fetal Growth Restriction
Recruiting
NAAges 18–65InterventionalTreatmentUniversity of Colorado, DenverInvestigator-initiated
~100 participants
Updated 2025-07-17 on ClinicalTrials.gov
What's tested:Left lateral recumbent positioning
At a glance
Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Fetal biometry
Measured over 4 weeks after enrollment
Conditions
Where it's being run
2 sites across 1 statesColorado2
Study leadership
- Manesha Putra, MD · PRINCIPAL_INVESTIGATOR · University of Colorado Anschutz, Department of Obstetrics and Gynecology
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Pregnant persons between 18 - 65 years of age, with a diagnosis of fetal growth restriction, with an estimated fetal weight less than tenth percentile
Participants with a singleton pregnancy between 24- and 34-weeks' gestational age
Participants with fluency in English or Spanish language
Exclusion
Patients with a known history of deep vein thrombosis, pulmonary embolism, or hypercoagulability disorder
Patients with a pre-pregnancy BMI greater than 40
Pregnancy with severe abnormality in umbilical artery Doppler flow, including absent end-diastolic flow (AEDF) and reverse end-diastolic flow (REDF)
Patients receiving anticoagulation therapy
Pregnancy with suspected chromosomal anomalies or a multifetal pregnancy
Patients with an active smoking status during pregnancy
What this trial measures
- Fetal biometry4 weeks after enrollment
Fetal estimated fetal weight and abdominal circumference will be assessed and compared to enrollment values